Feasibility and Benefits of Reflexology in the Prevention of Neuropathy Induced by Oxaliplatin in Colorectal Cancer
Condition(s) studied
Investigational drug(s) / intervention(s)
Foot reflexology: 30 minutes reflexology session
Study summary
The management of colorectal cancer often requires oxaliplatin-based chemotherapy, either as part of curative treatment plans or exclusively in palliative situations. Oxaliplatin therefore plays a key role in the management of colorectal cancer. In addition to its digestive and hematological toxicity, oxaliplatin frequently induces chronic, often limiting, sensitive peripheral neuropathy.
Only early discontinuation of oxaliplatin can limit the risk of clinically limiting neurotoxicity (grade ≥ 3).
In oncology, managing the side-effects of treatment is an essential objective of supportive care, and is open to a variety of complementary medicines, including reflexology. This technique, derived from traditional Chinese medicine, involves stimulating reflex points on the arch of the foot.
Eligibility
Primary outcome measure(s)
- number of sessions performed — 6 months
at least 50% of patients included and realized at least 70% of reflexology sessions over the 6-month treatment.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU de Toulouse | Toulouse | CHU de Toulouse | Recruiting |
More University Hospital, Toulouse trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06251297 on ClinicalTrials.gov ↗ ← All trials in France